SmartTab CEO to Speak at Formulation & Delivery UK Conference
By Sacha Heppell - August 18, 2021
SmartTab, a leading drug delivery technology startup, is honored to announce that Robert Niichel, Founder and CEO of SmartTab, will be presenting at Formulation & Delivery UK on the topics of Advanced Wireless Drug Delivery and our novel, patient-centric oral capsule platform for drug delivery. The conference brings together leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development.
Event Dates: September 21-22, 2021 | London, UK + Digital Day: September 23, 2021 | Online
SmartTab Presentation - Sept. 22
Advancing Wireless Ingestible Drug Delivery Technologies
The convergence of digital technologies and pharmaceutical delivery systems
PK pre-clinical proof of concept study that demonstrates successfully administering, via radio frequency signalling, active ingredients to the chosen target site
What this technology could hold for the future
Presented by Robert Niichel, Founder & Chief Executive Officer, SmartTab
The conference will feature a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook/ These global leaders will present the latest developments in drug delivery and combination products, and the novel developmental strategies and technologies for a range of innovative new therapeutic modalities.
SmartTab CEO, Robert Niichel, will be joined by leading industry and community leaders in the pharmaceutical and drug delivery space including companies such as Janssen, Jazz Pharmaceuticals, Medincell, Boehringer Ingelheim, and Neurelis.
Based in Denver, Colorado, SmartTab is engaged in the design, development and validation of next generation wireless drug delivery systems. The SmartTab technology platform is a personalized wireless solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is on a mission to provide novel effective therapies to improve patient outcomes and compliance.